Evaluation of the effects of probiotic supplementation from the neonatal period on innate immune development in infancy

Clinical and Experimental Allergy

Volumn 36, Issue 10, 2006, Pages 1218-1226

  Taylor, A ^a   Hale, J ^a   Wiltschut, J ^a   Lehmann, H ^a   Dunstan, J A ^a   Prescott, S L ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Allergy; Infant; Innate; Probiotics; TLR

Indexed keywords

CYTOKINE; HLA DR3 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P70; LIPOPOLYSACCHARIDE; MALTODEXTRIN; PLACEBO; PROBIOTIC AGENT; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ALLERGIC DISEASE; ALLERGY; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CELL FUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FLUORESCENCE; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LACTOBACILLUS ACIDOPHILUS; MAJOR CLINICAL STUDY; MONOCYTE; MONONUCLEAR CELL; NEWBORN PERIOD; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUPERNATANT;

ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTES; CYTOKINES; DENDRITIC CELLS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; HLA-DR ANTIGENS; HUMANS; HYPERSENSITIVITY; IMMUNE SYSTEM; INFANT; INFANT, NEWBORN; INTERLEUKIN-12; LACTOBACILLUS ACIDOPHILUS; LINEAR MODELS; LIPOPOLYSACCHARIDES; MONOCYTES; NEUTROPHILS; PROBIOTICS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 33749333612     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2006.02552.x     Document Type: Article

References (42)

1. Holt PG, Macaubas C, Prescott SL, Sly PD. Microbial stimulation as an aetiologic factor in atopic disease. Allergy 1999; 54 (Suppl. 49):12-6.
2. Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 2001; 1:69-75.
3. Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD. A Polymorphism* in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 1999; 20:976-83.
4. Beyer K, Nickel R, Freidhoff L et al. Association and linkage of atopic dermatitis with chromosome 13q12-14 and 5q31-33 markers. J Investigative Dermatol 2000; 115:906-8.
5. Eder W, Klimecki W, Yu L et al. Toll-like receptor 2 as a major gene for asthma in children of European farmers. J Allergy Clin Immunol 2004; 113:482-8.
6. Fageras Bottcher M, Hmani-Aifa M, Lindstrom A et al. A TLR4 polymorphism is associated with asthma and reduced lipopolysaccharide-induced interleukin-12(p70) responses in Swedish children. J Allergy Clin Immunol 2004; 114:561-7.
7. Hoffjan S, Nicolae D, Ostrovnaya I et al. Gene-environment interaction effects on the development of immune responses in the 1st year of life. Am J Hum Genet 2005; 76:696-704.
8. Koppelman GH, Reijmerink NE, Colin Stine O et al. Association of a promoter polymorphism of the CD14 gene and atopy. Am J Respir Crit Care Med 2001; 163:965-9.
9. Bjorksten B. Effects of intestinal microflora and the environment on the development of asthma and allergy. Springer Semin Immunopathol 2004; 25:257-70.
10. Bjorksten B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 1999; 29:342-6.
11. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001; 108:516-20.
12. Bottcher MF, Nordin EK, Sandin A, Midtvedt T, Bjorksten B. Microflora-associated characteristics in faeces from allergic and nonallergic infants. Clin Exp Allergy 2000; 30:1590-6.
13. Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001; 107:129-34.
14. Sepp E, Julge K, Vasar M et al. Intestinal microflora of Estonian and Swedish infants. Acta Paediatr 1997; 86:956-61.
15. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 35:1076-9.
16. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003; 361:1869-71.
17. Lammers KM, Brigidi P, Vitali B et al. Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 2003; 38:165-72.
18. Hart AL, Lammers K, Brigidi P et al. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 2004; 53:1602-9.
19. Benyacoub J, Czarnecki-Maulden GL, Cavadini C et al. Supplementation of food with Enterococcus faecium (SF68) stimulates immune functions in young dogs. J Nutr 2003; 133:1158-62.
20. Rehakova Z, Trebichavsky I, Sinkora J, Splichal I, Sinkora M. Early ontogeny of monocytes and macrophages in the pig. Physiol Res 1998; 47:357-63.
21. Macaubas C, Sly PD, Burton P et al. Regulation of T-helper cell responses to inhalant allergen during early childhood. Clin Exp Allergy 1999; 29:1223-31.
22. Upham JW, Holt BJ, Baron-Hay MJ et al. Inhalant allergen-specific T-cell reactivity is detectable in close to 100% of atopic and normal individuals: covert responses are unmasked by serum-free medium. Clin Exp Allergy 1995; 25:634-42.
23. Prescott SL, Taylor A, King B et al. Neonatal interleukin-12 capacity is associated with variations in allergen-specific immune responses in the neonatal and postnatal periods. Clin Exp Allergy 2003; 33:566-72.
24. Upham JW, Lee PT, Holt BJ et al. Development of interleukin-12-producing capacity throughout childhood. Infect Immun 2002; 70:6583-8.
25. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997; 159:1739-45.
26. Kumazaki K, Nakayama M, Yanagihara I, Suehara N, Wada Y. Immunohistochemical distribution of Toll-like receptor 4 in term and preterm human placentas from normal and complicated pregnancy including chorioamnionitis. Hum Pathol 2004; 35:47-54.
27. Blumer N, Herz U, Wegmann M, Renz H. Prenatal lipopolysaccharide-exposure prevents allergic sensitization and airway inflammation, but not airway responsiveness in a murine model of experimental asthma. Clin Exp Allergy 2005; 35:397-402.
28. Tulic MK, Wale JL, Holt PG, Sly PD. Modification of the inflammatory response to allergen challenge after exposure to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol 2000; 22:604-12.
29. Rachmilewitz D, Katakura K, Karmeli F et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004; 126:520-8.
30. Lan JG, Cruickshank SM, Singh JC et al. Different cytokine response of primary colonic epithelial cells to commensal bacteria. World J Gastroenterol 2005; 11:3375-84.
31. Riordan SM, Skinner N, Nagree A et al. Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis. Hepatology 2003; 37:1154-64.
32. Rescigno M, Urbano M, Valzasina B et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001; 2:361-7.
33. Christensen HR, Frokiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 2002; 168:171-8.
34. Borres MP, Bjorksten B. Peripheral blood eosinophils and IL-4 in infancy in relation to the appearance of allergic disease during the first 6 years of life. Pediatr Allergy Immunol 2004; 15:216-20.
35. Martinez FD, Stern DA, Wright AL, Holberg CJ, Taussig LM, Halonen M. Association of interleukin-2 and interferon-gamma production by blood mononuclear cells in infancy with parental allergy skin tests and with subsequent development of atopy. J Allergy Clin Immunol 1995; 96 (5 Part 1):652-60.
36. Prescott SL, Macaubas C, Smallacombe T, Holt BJ, Sly PD, Holt PG. Development of allergen-specific T-cell memory in atopic and normal children. Lancet 1999; 353:196-200.
37. Upham JW, Holt PG, Taylor A, Thornton CA, Prescott SL. HLADR expression on neonatal monocytes is associated with allergen-specific immune responses. J Allergy Clin Immunol 2004; 114:1202-8.
38. van der Velden VH, Laan MP, Baert MR, de Waal Malefyt R, Neijens HJ, Savelkoul HF. Selective development of a strong Th2 cytokine profile in high-risk children who develop atopy: risk factors and regulatory role of IFN-gamma, IL-4 and IL-10. Clin Exp Allergy 2001; 31:997-1006.
39. Ma D, Forsythe P, Bienenstock J. Live Lactobacillus reuteri is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect Immun 2004; 72:5308-14.
40. Arbour NC, Lorenz E, Schutte BC et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25:187-91.
41. Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including milk powder with live lactic acid bacteria. Cordoba, Argentina, 2001.
42. Joint FAO/WHO working group guidelines for the evaluation of probiotics in food. London, Ontario, Canada, 2002.